*By Conor White* President Trump took his latest shot at the New York Times Friday, [calling on Attorney General Jeff Sessions](https://www.cnn.com/2018/09/07/politics/donald-trump-jeff-sessions-investigation/index.html) to investigate the publication and find out who wrote the anonymous op-ed that rocked the White House this week. While the president has threatened to take action, legal experts haven't suggested the Times violated any laws in posting the piece, but the question of whether it *should* have remains. "I think it was ethically fine," Margaret Sullivan, Washington Post media columnist and former Public Editor for the New York Times, said Friday in an interview on Cheddar. "I think they do run up against some issues if they also decide to have reporters reveal the identity." In most newsrooms, the opinion and news sections operate as separate entities. But they may collide if the Times' own reporters begin to dig for answers, Sullivan said. "This op-ed piece was published by the opinion section, the news section presumably is free to pursue the story, but whether that separation is really going to be honored and be understood is another question." The paper should prepare for a legal battle, and the author should ready him or herself for the consequences, Sullivan said. After all, it seems Trump is arming himself for war. "We're looking at it very strongly from a legal point," the president said to reporters before boarding Air Force One on Friday. "We're going to take a look at what he had, what he gave, what he's talking about, also where he is right now." Trump has called the writer "gutless," and while Sullivan doesn't agree with that sentiment, she acknowledged that the anonymous nature of the piece is something of a detractor. "If you're going to say something like this that's so negative and so detrimental, it would be much more important to put your name behind it," she said. The Times only identified the writer as a "senior official". Many of President Trump's advisers, including Mike Pence, Steve Mnuchin, Sarah Huckabee Sanders, Mike Pompeo, and Nikki Haley, have adamantly denied they are behind the piece. But Sullivan doesn't think the author will be hidden for long. "I don't think this is going to be a case like Watergate's Deep Throat, where the person, Mark Felt, was a secret for actually decades from almost everyone, I think we're going to know who this person is." For full interview [click here](https://cheddar.com/videos/should-the-new-york-times-have-published-trump-op-ed).

Share:
More In Politics
SCOTUS Mississippi Abortion Rights Case 'Direct Challenge' to Roe v. Wade
The Supreme Court will be hearing arguments in Dobbs v. Jackson Women's Health on Wednesday over a Mississippi law banning abortions after 15 weeks. Jimmy Hoover, the Supreme Court editor-at-large for Law360, joined Cheddar to break down the momentous legal fight. "This is the biggest abortion case at the Supreme Court in 30 years," he said. "It is a … a direct challenge to Roe v. Wade."
Stocks Plummet Following Fed Chair Powell's Comments on Tapering
Matt Peron, Director of Research at Janus Henderson Investors, joins Cheddar News' Closing Bell, where he breaks down the factors leading to today's market slide and says there's more to it than Fed Chair Jerome Powell's comments about speeding up tapering efforts.
Walmart CEO Praises Biden Efforts to Ease Supply Chain Bottlenecks
Walmart CEO Dough McMillon praised the Biden administration's efforts to ease supply chain constraints after the company saw a 26 percent jump in shipments over the last month. President Joe Biden had announced back in October that California ports would operate on a 24/7 basis.
Omicron Risk, Barbados Drops Queen & Jack Logs Off
Jill and Carlo cover the latest developments with the Omicron variant that are spooking markets once again. Twitter's @Jack is leaving, SCOTUS takes up abortion rights and the world has a brand new republic.
U.S. to Buy 10 Million Courses of Pfizer Covid Pill
The Biden Administration is set to buy 10 million courses of Pfizer's Covid pill if it gains emergency use authorization from the FDA. With this purchase, the U.S. will receive more than 13 million courses of antiviral pills aimed at treating Covid and reducing severe illness and death. Pfizer's pill has been shown to reduce risk of hospitalization and death by 89 percent, proving it could be a key tool in the fight against the pandemic. Dr. Soumi Eachempati, Co-Founder, CEO & CMO of Cleared4, joined Cheddar News to discuss.
Breaking Down the Build Back Better Act's Impact on Affordable Housing
The Build Back Better Act has been at the center of endless negotiations and debate, ultimately landing as a nearly $1.8 trillion plan. One of the highlights is $170 billion dollars for affordable housing, making history as the largest investment in the sector to date. Eliza Collins, politics reporter for The Wall Street Journal, joins Cheddar News to break down the bill.
U.S. to Tap into Oil Reserves to Lower Prices at the Pump
The Biden Administration is releasing 50 million barrels of oil from the U.S. oil reserves in hopes of easing soaring gas prices. Vijay Vaitheeswaran, Global Energy and Climate Innovation Editor at the Economist, joined Cheddar to discuss.
Load More